Streptozotocin-induced diabetic and control rats were placed in one of two dietary groups and fed diets with a P/S ratio of 2.2 -2.3 for 4 weeks. The n-3/n-6 ratios in the dietary groups were 0.01 (SAF group) and 2.92 (PER group). A decrease in the 20:4n-6 level, and an increase in the 18:2n-6 level were observed in the erythrocyte lipids of diabetic rats of both dietary groups, as compared with the levels in control rats. The cholesterol/lipid-P ratio in erythrocyte lipids was significantly higher in diabetic rats than in control rats in both dietary groups, while the ratio in livers was significantly lower in diabetic rats. In liver phospholipids, the differences between the polyunsaturated fatty acid contents of control and diabetic rats in the SAF group, were almost identical to those in erythrocyte lipids. However, in the PER group, a small increase in the 20:4n-6 level, besides an obvious increase in the 18:2n-6 level, was observed in diabetic rats, and n-3 fatty acid levels, especially that of 20:5n-3, were lower significantly in diabetic rats than in control rats. Plasma triglyceride and cholesterol levels in diabetic rats were higher than those in control rats in both dietary groups. The two dietary groups showed significant different triglyceride levels, but similar cholesterol levels. It is suggested that the physiological effect of 18:3n-3 is impaired in diabetes in the same manner as that of 18:2n-6 is. Key Words arachidonic acid, eicosapentaenoic acid, cholesterol, liver, erythrocytes, diabetic rats A low level of insulin secretion, which is observed in insulin-dependent diabetes mellitus, induces metabolic disorders involving carbohydrates, proteins, and lipids. A decreased insulin level depresses lipid synthesis, but accelerates lipid catabolism. A low level of arachidonic acid (20:4n-6) is observed in diabetes, and an impairment of polyunsaturated fatty acid (PUFA) synthesis in diabetic animals results in an abnormal tissue PUFA profile, which in turn induces irregular eicosanoid metabolism. A decreased 20:4n-6 level and an increased linoleic acid 567
1 Oriental mix (Oriental Yeast Co., Tokyo). Figure 1 shows the weight gains of the control and diabetic rats. The weight gain of the STZ-injected diabetic rats was considerably less than that of the control rats, while no difference was observed between the dietary groups. There were also no differences between the liver weights of the dietary groups. 4n-6 levels were observed in diabetic rats, as compared with control rats, in both dietary groups. In addition, the 20:4n-6/18:2n-6 ratios in diabetic rats were lower than those in control rats. Regarding n-3 PUFAs, the 20:5n-3 level showed an insignificant change in diabetic rats, while the 22:5n-3 levels in diabetic rats were lower than in control rats in both dietary groups. The 22:6n-3 level in diabetic rats did not change in the SAF group, but decreased in the PER group, as compared with the levels in control rats. Furthermore, the n-3/n-6 ratio in the diabetic rats in the PER group decreased, due to the reduction of n-3 PUFA, while that in the SAF group did not change. In addition, the unsaturation index (UI), which was not affected by dietary fat, decreased in diabetic rats, as compared with its value in control rats. Table 4 shows the fatty acid profiles in liver phospholipids. The level of 18:2n -6 in diabetic rats, which was not affected by diet as in erythrocytes, was higher than that in control rats, while insignificant decreases and increases were observed in the 20:4n-6 levels of diabetic rats in the SAF and PER groups, respectively, as compared with the levels in the respective control rats. However, a significant decrease was observed in the 20:4n-6/18:2n-6 ratio in both dietary groups. The 20:Sn-3 levels in livers showed a strong correlation with dietary fat composition, and were undetectable in the livers of SAF rats which were fed trace amounts of n-3 fatty acid. Decreases in the levels of n-3 pentaenoic acids (20:5 and 22:5) were observed in the PER rats, but not in SAF rats. In both dietary groups, the difference between the 22:6n-3 levels in control and diabetic rats was insignificant. The n-3/n-6 ratios in PER group decreased in diabetic rats, as compared with those in control rats, while the ratio in the SAF group did not change. The unsaturation index, which was not affected by dietary fat, decreased in diabetic rats, as compared with its value in control rats.
RESULTS

Weight gains
Cholesterol/lipid-P
The cholesterol/lipid-P ratios in erythrocytes and livers are presented in Table  5 . The ratio was not affected by dietary fat. In erythrocytes, the ratio in diabetic rats was higher than that in control rats. On the other hand, in livers, the ratio in diabetic rats was lower than that in control rats. Cholesterol and lipid-P concentra tions in livers changed insignificantly in diabetic and control rats. Table 6 shows the plasma lipids levels. The triglyceride level, which was higher in SAF rats than in PER rats, increased in diabetic rats, as compared with the levels in control rats. Cholesterol levels also increased in diabetic rats , although the differences between dietary groups were insignificant. In the SAF group , an increase in the free cholesterol level was observed in diabetic rats , as compared with the level in control rats, and the ratio of cholesterol ester to total cholesterol (CE/C) decreased. The level of HDL-cholesterol and the ratio of HDL-cholesterol to total cholesterol in diabetic rats were higher than those in control rats, while the difference between the HDL-cholesterol levels of the two dietary groups was insignificant.
Plasma lipids
DISCUSSION
Depletion of insulin secretion in diabetes is known to induce some disorders related to hepatic lipogenesis and apolipoprotein metabolism, and result in enhance ment of plasma lipid levels and abnormality in biomembrane including blood cells and tissues (11). Erythrocytes does not have an ability of lipogenesis, and the lipid composition of erythrocytes in directly affected by the plasma lipid profile flowed out from a liver (12). In this study, the lipid compositions of erythrocytes and livers were examined for estimates of alterations of hepatic lipogenesis including PUFA synthesis and cholesterol/lipid-P ratio which modulates biomembrane prop erty induced by diabetes, respectively.
Insulin enhances lipogenesis by activating HMG-CoA reductase , glycerol phosphate acyltransferase, acetyl-CoA carboxylase, fatty acid synthetase, fatty acid desaturases, and so on. Depressed fatty acid desaturase activity in diabetes has been demonstrated by direct enzyme assay (5-7) together with a decreased 20:4n-6 level and an increased 18:2n-6 level (1-4). We also observed decreased 20:4n-6/l8:2n -6 ratios in the erythrocytes and livers of diabetic rats, as compared with the values in control rats (Tables 3 and 4) . In erythrocyte lipids, most unsaturated fatty acid levels significantly decreased in diabetic rats, as compared with those in control rats, except for 18:2n-6 and 20:5n-3 in both dietary groups, and 22:6n-3 in the SAF group. Arachidonic acid is the precursor in prostaglandin in 2 series including thromboxane A2 and prostaglandin 12, of which synthesis is antagonized by n-3 fatty acid, particularly 20:5n-3. Consequently, the present observation that the 20: 4n-6/20:5n-3 ratio in the PER group was greater in diabetic rats than in control rats, as opposed to the finding in the SAF group, is interesting. As a result of the decreased PUFA levels and the increased cholesterol/lipid-P ratio (Table 5) , the fluidity of erythrocyte membranes, which is controlled by the unsaturation degree of phospholipids (13) and the cholesterol/phospholipid ratio (14), may have been reduced. In livers, the cholesterol/lipid-P ratios in diabetic rats ly, may be due to homeostasis to preserve these fatty acids under deficient conditions, in addition to decreases in other fatty acids. Dietary n-3 fatty acids has been shown to reduce the level of serum or plasma lipids, particularly that of triglyceride (22) . The low level of plasma TG level reflects the suppressed TG secretion by the liver and the enhanced ketogenesis induced by n-3 PUFA (23) . In the present study, the plasma triglyceride level in the PER group was lower than that in the SAF group, while an increase was observed in diabetic rats in both the SAF and PER groups (Table 6 ). An increased plasma TG level in diabetes is induced by a removal defect of TG rich lipoproteins (24, 25) . The TG-lowering effect of n-3 fatty acid may have been weakened by metabolic disorders in diabetes. In addition, HDL-cholesterol levels increased in diabetic rats, particularly those in the PER group. An increased cholesteryl ester may have remained in HDL, considering that rats have a poor ability of transfer ring cholesteryl ester from HDL to LDL (26) .
In the present study, a significant decrease of n 3 PUFA in livers and erythrocytes of rats fed perilla oil was observed. The finding suggests that the synthesis of n-3 long chain PUFA from 18:3n-3 is impaired in diabetes in the same manner as that of 20:4n-6 from 18:2n-6 is. Considering that the clinical disorders in diabetic patients are often improved by doses of r-linolenic aicd (18:3n-6) (27), the beneficial effect of dietary fish oil containing 20:5n-3 and 22:6n-3 may be expected more than that of dietary 18:3n-3.
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